Literature DB >> 19787237

Aberrant promoter hypermethylation of the CHFR gene in oral squamous cell carcinomas.

Seiji Baba1, Akira Hara, Keizo Kato, Nguyen Khanh Long, Yuichiro Hatano, Masashi Kimura, Yukio Okano, Yasuhiro Yamada, Toshiyuki Shibata.   

Abstract

Recent studies have shown that promoter hypermethylation of tumor suppressor genes is an important factor in carcinogenesis of several human organs. The purpose of this study was to examine the methylation status of CHFR, a novel cell cycle regulatory gene, in both primary oral cancer tumors and the adjacent normal mucosa, and to clarify the relation between the methylation status and expression of the CHFR-related chromosomal passenger protein Aurora-A. The methylation status of the CHFR gene was examined by the methylation-specific PCR (MSP) in 49 primary oral squamous cell carcinomas (OSCC) and 6 OSCC cell lines. In 13 cases, the adjacent normal oral mucosal tissues were also examined. Normal oral mucosa from 18 healthy volunteers was used as the control. The mRNA level of Aurora-A and CHFR in OSCC cell lines was investigated by real-time RT PCR and the protein expression of Aurora-A in certain tumor samples was confirmed by immunohistochemistry. Aberrant promoter methylation of the CHFR gene was detected in 34.7% (17 of 49) of OSCC cases. As for the 13 OSCC cases with paired cancerous and adjacent normal tissues, promoter hypermethylation of the CHFR gene was detected in 46.1% (6 of 13) of the cancerous tissues. In contrast, promoter hypermethylation of the CHFR gene was recognized in only 7.7% (1 of 13) of the surrounding normal mucosa. No hypermethylation of the CHFR gene was detected in healthy volunteers. Only one OSCC cell line shows hypermethylation of the CHFR gene with concurrently silenced mRNA expression, however, Aurora-A was expressed abundantly in all cell lines. Furthermore, there is no significant relationship between methylation status of the CHFR gene and Aurora-A protein expression in OSCC. Hypermethylation of the CHFR gene was detected in a certain part of OSCC cases whereas it had very low frequency in adjacent normal oral tissues. Although further study is needed, Aurora-A gene expression seems to be independent from methylation status of the CHFR gene in OSCC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19787237     DOI: 10.3892/or_00000552

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  9 in total

1.  Interleukin-6 promotes tumorigenesis by altering DNA methylation in oral cancer cells.

Authors:  Jacqueline A Gasche; Jürgen Hoffmann; C Richard Boland; Ajay Goel
Journal:  Int J Cancer       Date:  2011-01-07       Impact factor: 7.396

Review 2.  Epigenetic mechanisms in oral carcinogenesis.

Authors:  Jacqueline A Gasche; Ajay Goel
Journal:  Future Oncol       Date:  2012-11       Impact factor: 3.404

3.  Regulation of AURKC expression by CpG island methylation in human cancer cells.

Authors:  Satoshi Fujii; Vibhuti Srivastava; Apurva Hegde; Yutaka Kondo; Lanlan Shen; Koyu Hoshino; Yvette Gonzalez; Jin Wang; Kaori Sasai; Xiaotu Ma; Hiroshi Katayama; Marcos R Estecio; Stanley R Hamilton; Ignacio Wistuba; Jean-Pierre J Issa; Subrata Sen
Journal:  Tumour Biol       Date:  2015-05-20

Review 4.  CHFR: a key checkpoint component implicated in a wide range of cancers.

Authors:  Sheru Sanbhnani; Foong May Yeong
Journal:  Cell Mol Life Sci       Date:  2011-12-13       Impact factor: 9.261

5.  Detecting Early-Stage Oral Cancer from Clinically Diagnosed Oral Potentially Malignant Disorders by DNA Methylation Profile.

Authors:  Kazuki Mori; Tomofumi Hamada; Mahiro Beppu; Hiroki Tsuchihashi; Yuichi Goto; Kenichi Kume; Hiroshi Hijioka; Keitaro Nishi; Yumiko Mishima; Tsuyoshi Sugiura
Journal:  Cancers (Basel)       Date:  2022-05-26       Impact factor: 6.575

6.  Role of DNA methylation in head and neck cancer.

Authors:  Semra Demokan; Nejat Dalay
Journal:  Clin Epigenetics       Date:  2011-07-09       Impact factor: 6.551

7.  DNA methylation induced epigenetic silencing: a potential biomarker and therapeutic target for head and neck squamous cell carcinoma.

Authors:  Shankargouda Patil; Roopa Rao; Thirumal Raj
Journal:  J Int Oral Health       Date:  2015-04

Review 8.  p16INK4A and p14ARF gene promoter hypermethylation as prognostic biomarker in oral and oropharyngeal squamous cell carcinoma: a review.

Authors:  A Al-Kaabi; L W van Bockel; A J Pothen; S M Willems
Journal:  Dis Markers       Date:  2014-04-07       Impact factor: 3.434

Review 9.  Emerging evidence for CHFR as a cancer biomarker: from tumor biology to precision medicine.

Authors:  Sarah Derks; Arjen H G Cleven; Veerle Melotte; Kim M Smits; Johann C Brandes; Nilofer Azad; Wim van Criekinge; Adriaan P de Bruïne; James G Herman; Manon van Engeland
Journal:  Cancer Metastasis Rev       Date:  2014-03       Impact factor: 9.264

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.